tetrabenazine — Medical Mutual
Tardive Dyskinesia
Initial criteria
- Patient age ≥ 18 years
- Medication is prescribed by or in consultation with a neurologist or psychiatrist
Reauthorization criteria
- Response to therapy is required for continuation of therapy
Approval duration
1 year